What is the appropriate management for a severely dilated right ventricle?

Management of Severely Dilated Right Ventricle

The management of a severely dilated right ventricle requires immediate identification and treatment of the underlying cause, with priority given to optimizing preload, reducing afterload through pulmonary vasodilators, and supporting contractility with inotropes while avoiding excessive fluid administration that worsens RV distention.

Diagnostic Evaluation

Immediate Assessment with Echocardiography

Perform transthoracic echocardiography (or transesophageal if image quality is poor) to assess 1, 2:

• RV size: Calculate RV end-diastolic area (RVEDA) to LV end-diastolic area (LVEDA) ratio
  • Ratio 0.6-1.0 = moderate RV dilation
  • Ratio >1.0 = severe RV dilation
• Acute cor pulmonale: RVEDA/LVEDA >0.6 plus paradoxical septal motion during end-systole 2
• Septal position: Leftward deviation indicates RV pressure/volume overload 1, 3
• RV systolic function: Measure TAPSE (tricuspid annular plane systolic excursion)
• Tricuspid regurgitation severity and inferior vena cava size (assess right atrial pressure) 1

Identify the Underlying Cause

Primary RV pathology 4:

• Arrhythmogenic RV cardiomyopathy (look for ventricular arrhythmias, family history, characteristic ECG changes)
• Post-myocarditis cardiomyopathy
• Congenital heart disease (tetralogy of Fallot, pulmonary stenosis)

Secondary causes 4:

• Pulmonary hypertension (measure pulmonary artery systolic pressure)
• Left heart failure with elevated LV filling pressures
• Valvular disease (severe tricuspid or pulmonary regurgitation/stenosis)
• Pulmonary embolism (look for RV strain pattern, floating thrombus)
• Post-LVAD implantation 1

Advanced Hemodynamic Monitoring

For severe cases not responding to initial therapy, insert pulmonary artery catheter to measure 2:

• Pulmonary artery pressure and pulmonary artery occlusion pressure
• Calculate pulmonary vascular resistance
• Monitor cardiac output and mixed venous oxygen saturation

Hemodynamic Management

Preload Optimization

Critical principle: Avoid excessive fluid administration in severely dilated RV 3

• Excess fluid increases RV distention, displaces septum leftward, obliterates LV cavity, and reduces cardiac output
• Risk of right-sided myocardial infarction with overdistention 3
• Use central venous pressure monitoring: target CVP that maintains adequate perfusion without worsening RV dilation 2
• If volume depleted (low CVP, small IVC), give cautious fluid boluses with echocardiographic reassessment

Afterload Reduction (Pulmonary Vasodilators)

Reduce pulmonary vascular resistance to decrease RV workload 3:

• Inhaled nitric oxide: 5-40 ppm (monitor methemoglobin every 6 hours, avoid abrupt discontinuation)
• Inhaled prostacyclin: 10-50 ng/kg/min
• Sildenafil: 20 mg three times daily PO or via nasogastric tube
• Intravenous prostacyclin: Start 1-2 ng/kg/min via central line, titrate to effect (watch for systemic hypotension)

Avoid factors that increase pulmonary vascular resistance 3:

• Hypoxia
• Acidosis
• Hypercapnia

Contractility Support (Inotropes)

Improve RV output and promote pulmonary vasodilation 3:

• Dobutamine: 2.5-5.0 mcg/kg/min (higher doses cause tachycardia that compromises RV filling)
• Milrinone: 0.25-0.75 mcg/kg/min (main side effect is systemic hypotension)

Blood Pressure Support (Vasopressors)

For hypotension, maintain coronary perfusion pressure 3:

• Norepinephrine: 0.05-3.3 mcg/kg/min
• Vasopressin: as alternative or adjunct

Specific Clinical Scenarios

Post-LVAD RV Failure

Check for 1:

• Pericardial effusion/tamponade causing RV compression
• LVAD pump speed too high (increases tricuspid regurgitation via septal shift, increases RV preload)
• Adjust pump speed if excessive LV unloading (LV dimension <3 cm, marked septal deviation toward LV)

Repaired Tetralogy of Fallot with Severe Pulmonary Regurgitation

Pulmonary valve replacement indicated for 5:

• Symptomatic patients with severe PR
• Asymptomatic patients with severe PR plus:
  • Moderate-severe RV dysfunction
  • Moderate-severe RV enlargement (RVEDV ≥160 mL/m² or RVESV ≥80 mL/m²)
  • Sustained atrial/ventricular arrhythmias
  • Moderate-severe tricuspid regurgitation

Pulmonary Hypertension/Cor Pulmonale

Focus on 4:

• Treat underlying pulmonary disease
• Optimize oxygenation
• Diuretics for symptom relief (but avoid over-diuresis causing reduced cardiac output)
• Anticoagulation with warfarin if high thromboembolism risk
• Disease-specific therapies: calcium channel blockers, endothelin receptor antagonists, prostacyclin analogs

Mechanical Circulatory Support

For refractory RV failure despite maximal medical therapy, consider 6:

• Impella RP: percutaneous RV support device
• ProtekDuo: right atrial to pulmonary artery support
• VA-ECMO: for biventricular failure
• Bridge to recovery, transplantation, or durable support

Critical Pitfalls to Avoid

1. Do not aggressively fluid resuscitate a severely dilated RV—this worsens ventricular interdependence and reduces cardiac output 3

2. Do not miss LVAD-related causes of RV failure (pump speed too high, pericardial tamponade) 1

3. Do not use systemic vasodilators alone for hypotension—they worsen RV perfusion; use vasopressors to maintain coronary perfusion pressure 3

4. Recognize declining pulmonary artery pressure with persistent high pulmonary vascular resistance as an ominous sign of decompensation 7

5. Monitor for progression from initial RV failure to subsequent LV failure (typically occurs minutes to hours after presentation in acute settings like amniotic fluid embolism) 3

Specialist Referral

Refer immediately to 4:

• Advanced heart failure/cardiomyopathy specialist for evaluation
• Cardiac surgery if structural intervention needed (valve repair/replacement, RVOT reconstruction)
• Transplant center if refractory to medical therapy